Stratview Research published a new report titled Global Proton Pump Inhibitors (PPIs) Market report is segmented By Drug Type (Over-the-counter Drugs [Omeprazole, Lansoprazole, Esomeprazole, Others], Prescription Drugs [Rabeprazole, Dexlansoprazole, Pantoprazole, Others]), By Disease (Ulcers, Gastroesophageal Reflux Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Region – COVID-19 Impact Analysis and Forecast to 2026.
The report published by Stratview Research covers exclusive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides an in-depth analysis of the market segments that includes products, applications, services, and competitor analysis, etc.
Get a free sample report here: https://www.stratviewresearch.com/Request-Sample/1660/proton-pump-inhibitors-(PPIs)-market.html#form
Key players
Some of the key companies that are profiled in this report are:
- AstraZeneca PLC/AB (UK),
- Bayer AG (Germany),
- Pfizer Inc. (The U.S),
- Cadila Pharmaceuticals Limited (India),
- Eisai Pharmaceuticals India Pvt. Ltd (India),
- Santarus, Inc. (The U.S),
- Wyeth, LLC (The U.S),
- Janssen Pharmaceutical (Belgium),
- Takeda Pharmaceutical Company Limited (Japan), and
- Sanofi S.A. (France)
The ‘Proton Pump Inhibitors (PPIs) Market’ report delivers a close watch on the active competitors, pricing analysis and a thorough overview of the market situations in the forecast period. It is a detailed report gathered from in-depth primary and secondary drivers, market shares, market segments, and geographical analysis.
Key Benefits for Industry players and new entrants:
The report delivers several insights into the Proton Pump Inhibitors (PPIs) Market that benefits the current industry players as well as those who are planning to enter the market. Below given are few benefits offered in the report-
- Market drivers, restraints, and challenges highlighted in the report
- Recent industry trends and developments are mentioned
- Neutral perspective on the market performance related to shares, supply and chain, etc.
- Competitive landscape & growth strategies of key players
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Proton Pump Inhibitors (PPIs) Market
- Overview of the regional outlook of the market.
- The market structure, historical data and forecasts for the coming years.
- Developments and trends in the market.
Segment-wise analysis
Based on drug type, the global proton pump inhibitors market has been bifurcated into over-the-counter drugs and prescription drugs. The over-the-counter drugs segment is further categorized into omeprazole, lansoprazole, esomeprazole, and others. Among these, the esomeprazole under the OTC drug segment garnered the highest market share in 2020 and is likely to grow at a healthy CAGR during the forecast timeline. Esomeprazole is mainly indicated to treat the symptoms of heartburn, Gastroesophageal Reflux Disease (GERD), and other disorders such as excessive stomach acids, thus bolstering the segment growth.
By region, the North American market accounted for the largest market share in 2020 and is estimated to grow at a steady CAGR during the assessment period. This can be attributed to increasing approvals of proton pump inhibitor products and the increasing prevalence of GERD in the US, Canada, and Mexico, which proliferates the industry growth in the region. Moreover, GERD affects almost 20% of adults in the US, thereby making the disease an important concern, which propels regional growth.
Many scientists have found that PPIs have increased the risk of COVID-19 in patients taking these medications. In 2020, the researchers of the American Journal of Gastroenterology carried out a research in which more than 53,000 people taking PPIs participated, of which 3,386 were tested positive for COVID-19. This is likely to negatively impact the market growth as the patients undergoing PPI therapy are recommended to consume less medication and avoid these medications unless it is an emergency.
The Proton Pump Inhibitors (PPIs) Market report can help the users in developing an understanding of the current market dynamics, supply chain analysis, pricing trends, product preferences, target audience & more.
About Stratview Research
Stratview Research is a global market research firm with capabilities of providing complex market reports and other consulting services. Along with market reports, the firm also provides custom research services across the sectors covering industries like Energy Chemicals, Advanced Materials, Automotive, and Aerospace, and more.
In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.